| Peer-Reviewed

Dural Metastasis with Subdural Hemorrhage from Prostate Cancer

Received: 13 August 2017    Accepted: 28 August 2017    Published: 18 December 2017
Views:       Downloads:
Abstract

A subdural hematoma (SDH) is usually traumatic in etiology. Non-traumatic instances of SDH are uncommon, and are rarely due to metastases involving the dura. We report a 68-year-old male patient with a one day history of, not communicating and not mobilizing and a 2 weeks history of generalized body weakness. A computed tomography (CT) scan revealed a left sided hypo-dense subdural collection. A diagnosis of left sided chronic subdural hematoma (SDH) was made. Burr hole drainage of the hematoma was performed. Intra- operatively, liquefied blood was drained and a thick dura with reddish material infiltrating the dura was noted. A specimen of the dura was submitted for histology and revealed metastatic carcinoma, confirmed at immunohistochemistry to be of prostatic origin. Conclusion: Metastatic disease should be considered when there is a chronic subdural hematoma with no history of trauma and an unusual dural appearance on imaging.

Published in International Journal of Neurologic Physical Therapy (Volume 3, Issue 6)
DOI 10.11648/j.ijnpt.20170306.11
Page(s) 49-53
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Prostate Cancer, Dural Metastases, Subdural Hematoma

References
[1] Kleinschmidt-DeMasters BK: Dural metastases. A retrospective surgical and autopsy series. Arch Pathol Lab Med 125: 880–887, 2001.
[2] McKenzie CR, Rengachary SS, McGregor DH, Dixon AY, Suskind DL: Subdural hematoma associated with metastatic neoplasms. Neurosurgery 27: 619–624; discussion 624–625, 1990.
[3] Meyer P C, Reah T G. Secondary neoplasms of the central nervous system and meninges. Br J Cancer. 1953; 7(4): 438–448.
[4] Soto-Ares G, Denes M, Noule N, Vinchon M, Pruvo JP, Gosset D. Subdural hematomas in children: role of cerebral and spinal MRI in the diagnosis of child abuse. J Radiol. 2003 Nov; 84(11 Pt 1): 1757-65.
[5] Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre J Y. Dural metastases. J Neurooncol. 2005; 75(1): 57–61.
[6] Benjamin R, Neurologic complications of prostate cancer, Am Fam Physician. 2002 May 1; 65(9): 1834-40.
[7] Tremont-Lukats et al. Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center Experience. Cancer 2003; 98: 363–368.
[8] Bobustuc G, Lagos G K, Lolas K, Kyritsis A P, Puduvalli V K. Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience. Cancer. 2003; 98(2): 363–368.
[9] Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM. Openings between defective endothelial cells explain tumor vessel leakiness. American Journal of Pathology 2000; 156: 1363-1380.
[10] De la Fouchardiere C, Flechon A. Droz JP. Coagulopathy in prostate cancer. Netherlands. The Journal of Medicine. 2003; 61(11): 347-354.
[11] O’Meara C, Mahasneh T, Wilson P, I’Ons B, Alkhawaja D. Dural prostate metastasis resembling a chronic subdural haematoma. JSCR 2012 5: 7.
[12] Rumana CS, Hess HR, Shi WM, Sawaya R. Metastatic brain tumors with Dural extension. J Neurosurg 1998; 89; 552-558.
[13] Benjamin R, Neurologic complications of prostate cancer, Am Fam Physician. 2002 May 1; 65(9): 1834-40.
[14] Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996; 53: 6 26-32.
[15] DeAngelis LM. Metastatic disease of the nervous system. Curr Treat Options Neurol 1999; 1: 409-16.
[16] J. L. Navarro-Olvera∗, E. Ari˜nez-Barahona, M. A. Esqueda-Liquidano, A. Mu˜noz-Cobos, Brain metastases: Literature review, Rev Med Hosp Gen Méx. 2017; 80(1): 60---66.
[17] Wolff JM, Bares R, Jung PK, Buell U, Jakse G. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer. Urol Int 1996; 56: 169-73.
[18] Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly Diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 54: 1886-93.
[19] Micali G, Linthicum K, Han N, West DP. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy 1999; 19: 223-7.
[20] Gupta A, Baidas S, Cumberlin RK. Brain stem metastasis as the only site of spread in prostate carcinoma. A case report. Cancer 1994; 74: 2516-9.
[21] Patchell RA. The treatment of brain metastases. Cancer Invest 1996; 14: 169-77.
[22] Deepak Khuntia, Contemporary Review of the Management of Brain Metastasis with Radiation Hindawi Publishing Corporation Advances in Neuroscience Volume 2015, Article ID 372856, 13 pages.
[23] Ajay Niranjan, MD, MBA and L. Dade Lunsford, MD, Gamma Knife Radiosurgery for 5 to 10 Brain Metastases: A Good Option for Upfront Treatment, Oncology Journal, Brain Tumors, April 15, 2016, Oncology (Williston Park). 30(4): 314–315, 317.
[24] Fervenza FC, Wolanskyj AP, Eklund HE, Richardson RL. Brain metastasis: an unusual complication from prostatic adenocarcinoma. Mayo Clinic Proc 2000; 75: 79-82.
Cite This Article
  • APA Style

    Kantenga Dieu Merci Kabulo, Nathaniel Harunangoni Zimani, Aaron Masiiwe Musara, Patrice Ntenga, Khita Phiri, et al. (2017). Dural Metastasis with Subdural Hemorrhage from Prostate Cancer. International Journal of Neurologic Physical Therapy, 3(6), 49-53. https://doi.org/10.11648/j.ijnpt.20170306.11

    Copy | Download

    ACS Style

    Kantenga Dieu Merci Kabulo; Nathaniel Harunangoni Zimani; Aaron Masiiwe Musara; Patrice Ntenga; Khita Phiri, et al. Dural Metastasis with Subdural Hemorrhage from Prostate Cancer. Int. J. Neurol. Phys. Ther. 2017, 3(6), 49-53. doi: 10.11648/j.ijnpt.20170306.11

    Copy | Download

    AMA Style

    Kantenga Dieu Merci Kabulo, Nathaniel Harunangoni Zimani, Aaron Masiiwe Musara, Patrice Ntenga, Khita Phiri, et al. Dural Metastasis with Subdural Hemorrhage from Prostate Cancer. Int J Neurol Phys Ther. 2017;3(6):49-53. doi: 10.11648/j.ijnpt.20170306.11

    Copy | Download

  • @article{10.11648/j.ijnpt.20170306.11,
      author = {Kantenga Dieu Merci Kabulo and Nathaniel Harunangoni Zimani and Aaron Masiiwe Musara and Patrice Ntenga and Khita Phiri and Kazadi Kaluile Ntenga Kalangu and Rudo Makunike Mutasa},
      title = {Dural Metastasis with Subdural Hemorrhage from Prostate Cancer},
      journal = {International Journal of Neurologic Physical Therapy},
      volume = {3},
      number = {6},
      pages = {49-53},
      doi = {10.11648/j.ijnpt.20170306.11},
      url = {https://doi.org/10.11648/j.ijnpt.20170306.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijnpt.20170306.11},
      abstract = {A subdural hematoma (SDH) is usually traumatic in etiology. Non-traumatic instances of SDH are uncommon, and are rarely due to metastases involving the dura. We report a 68-year-old male patient with a one day history of, not communicating and not mobilizing and a 2 weeks history of generalized body weakness. A computed tomography (CT) scan revealed a left sided hypo-dense subdural collection. A diagnosis of left sided chronic subdural hematoma (SDH) was made. Burr hole drainage of the hematoma was performed. Intra- operatively, liquefied blood was drained and a thick dura with reddish material infiltrating the dura was noted. A specimen of the dura was submitted for histology and revealed metastatic carcinoma, confirmed at immunohistochemistry to be of prostatic origin. Conclusion: Metastatic disease should be considered when there is a chronic subdural hematoma with no history of trauma and an unusual dural appearance on imaging.},
     year = {2017}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Dural Metastasis with Subdural Hemorrhage from Prostate Cancer
    AU  - Kantenga Dieu Merci Kabulo
    AU  - Nathaniel Harunangoni Zimani
    AU  - Aaron Masiiwe Musara
    AU  - Patrice Ntenga
    AU  - Khita Phiri
    AU  - Kazadi Kaluile Ntenga Kalangu
    AU  - Rudo Makunike Mutasa
    Y1  - 2017/12/18
    PY  - 2017
    N1  - https://doi.org/10.11648/j.ijnpt.20170306.11
    DO  - 10.11648/j.ijnpt.20170306.11
    T2  - International Journal of Neurologic Physical Therapy
    JF  - International Journal of Neurologic Physical Therapy
    JO  - International Journal of Neurologic Physical Therapy
    SP  - 49
    EP  - 53
    PB  - Science Publishing Group
    SN  - 2575-1778
    UR  - https://doi.org/10.11648/j.ijnpt.20170306.11
    AB  - A subdural hematoma (SDH) is usually traumatic in etiology. Non-traumatic instances of SDH are uncommon, and are rarely due to metastases involving the dura. We report a 68-year-old male patient with a one day history of, not communicating and not mobilizing and a 2 weeks history of generalized body weakness. A computed tomography (CT) scan revealed a left sided hypo-dense subdural collection. A diagnosis of left sided chronic subdural hematoma (SDH) was made. Burr hole drainage of the hematoma was performed. Intra- operatively, liquefied blood was drained and a thick dura with reddish material infiltrating the dura was noted. A specimen of the dura was submitted for histology and revealed metastatic carcinoma, confirmed at immunohistochemistry to be of prostatic origin. Conclusion: Metastatic disease should be considered when there is a chronic subdural hematoma with no history of trauma and an unusual dural appearance on imaging.
    VL  - 3
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe

  • Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe

  • Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe

  • Neurological Clinic of the National Teaching Hospital-FANN, Dakar, Senegal

  • Department of Pathology, University of Zimbabwe, Harare, Zimbabwe

  • Department of Neurosurgery, University of Zimbabwe, Harare, Zimbabwe

  • Department of Pathology, University of Zimbabwe, Harare, Zimbabwe

  • Sections